Global Neuroendocrine Carcinoma market size is expected to reach $2.47 billion by 2030 at 7.1%, growth of targeted therapies driving the market expansion
Read MoreGlobal Neurodiagnostics market size is expected to reach $13.48 billion by 2030 at 6.5%, rising prevalence of neurological disorders driving growth in the market
Read MoreOptical Genome Mapping market size is expected to reach $0.74 billion by 2030 at 25.9%, segmented as by instruments, optical genome mapping systems, imaging systems, detection and analysis devices
Read MoreGlobal Optic Neuropathy Management market size is expected to reach $5.07 billion by 2030 at 5.7%, growing prevalence of eye disease fuels the market
Read MoreOptic Nerve Disorders Treatment market size is expected to reach $5.21 billion by 2030 at 5.7%, segmented as by steroidal therapy, corticosteroids, intravitreal steroid injections, oral steroids
Read MoreGlobal Optic Atrophy Management market size is expected to reach $12.32 billion by 2030 at 6.7%, segmented as by disulfiram, oral disulfiram, injectable disulfiram
Read MoreGlobal Opioid-Induced Constipation Treatment market size is expected to reach $2.54 billion by 2030 at 5.9%, segmented as by laxatives, osmotic laxatives, stimulant laxatives, bulk-forming laxatives
Read MoreOpioid use disorder market to reach $7.82 billion by 2030 at 12.5% cagr, driven by growing number of opioid addiction cases.
Read MoreOphthalmoplegia market size is expected to reach $2.95 Billion by 2030 at 9.8%, driven by increasing incidence of neurological disorders.
Read MoreGlobal Ophthalmology Medical Service market size is expected to reach $65.9 by 2030 at 6%, rise in screen time driving growth of the market due to increasing pediatric eye conditions
Read More